Free Newsletter
Mumps outbreak spurs calls for a new vaccine
Health experts say that an outbreak of mumps two years ago among college students occurred even though most of them had received a recommended vaccine. And a number of physicians have concluded that that failure underscores the need for a new vaccine. In the meantime, adding a third dose of the currently used vaccine may be the best way to head off any renewed outbreak.
The outbreak in the Midwest hit thousands of people--making it the worst in almost 20 years. And 84 percent of the patients who knew for sure whether they had been vaccinated had been vaccinated against mumps, according to a study by the Centers for Disease Control and Prevention and state health departments. Researchers believe that a new strain of mumps that originated in the U.K. was probably responsible for the outbreak.
"It may be time to be developing a new vaccine," Pam Shaw, a pediatrician at the University of Kansas Medical Center, tells the Kansas City Star.
- read the report for more
Related Articles:
Chiron pulls MMR vaccine off the market
WHO: Infectious disease a growing threat
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: